Health - Bloomberg
Skip to content
Bloomberg the Company & Its ProductsThe Company & its ProductsBloomberg Terminal Demo RequestBloomberg Anywhere Remote LoginBloomberg Anywhere LoginBloomberg Customer SupportCustomer Support
BloombergConnecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
For CustomersBloomberg Anywhere Remote LoginSoftware UpdatesManage Products and Account Information
SupportAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000
CompanyAboutCareersInclusion at BloombergTech at BloombergPhilanthropySustainabilityBloomberg Beta
CommunicationsPress AnnouncementsPress Contacts
FollowFacebookInstagramLinkedInYouTube
ProductsBloomberg TerminalDataTradingRiskComplianceIndices
Industry ProductsBloomberg LawBloomberg TaxBloomberg GovernmentBloombergNEF
MediaBloomberg MarketsBloomberg TechnologyBloomberg PursuitsBloomberg PoliticsBloomberg OpinionBloomberg BusinessweekBloomberg Live ConferencesBloomberg RadioBloomberg TelevisionNews Bureaus
Media ServicesBloomberg Media DistributionAdvertising
CompanyAboutCareersInclusion at BloombergTech at BloombergPhilanthropySustainabilityBloomberg Beta
CommunicationsPress AnnouncementsPress Contacts
FollowFacebookInstagramLinkedInYouTube
ProductsBloomberg TerminalDataTradingRiskComplianceIndices
Industry ProductsBloomberg LawBloomberg TaxBloomberg GovernmentBloombergNEF
MediaBloomberg MarketsBloomberg TechnologyBloomberg PursuitsBloomberg PoliticsBloomberg OpinionBloomberg BusinessweekBloomberg Live ConferencesBloomberg RadioBloomberg TelevisionNews Bureaus
Media ServicesBloomberg Media DistributionAdvertising
BloombergConnecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
For CustomersBloomberg Anywhere Remote LoginSoftware UpdatesManage Contracts and Orders
SupportAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000
Sign InSubscribeSearchLive TVMarketsChevron DownEconomicsIndustriesTechPoliticsBusinessweekOpinionMoreChevron DownUS EditionChevron DownMenuSubscribeHealthIndustriesEnergyEntertainmentFinanceConsumerReal EstateLegalTransportationTelecomSportsSpaceCFOTO/Future Publishing/Getty ImagesYao Ming-Backed Chinese Gym Chain Supermonkey Is Said to Mull Stake SaleBloomberg OpinionBloomberg OpinionThis Crackdown on Drug Ads Is Long OverduePresident Trump’s order for tighter rules is a good start, but to succeed it needs tough enforcement and adequate resources.  By Lisa Jarvis, ColumnistDomestic Violence Is a Real Crime. My Mother Worked to Make It One.By Mary Ellen Klas, ColumnistAdvanced Prostate Cancer Is Rising. That’s Preventable.By Lisa Jarvis, ColumnistRFK Jr.’s Vision for the CDC Should Alarm CongressEditorial BoardSean Dong for Bloomberg BusinessweekHow Hims Became the King of Knockoff Weight-Loss DrugsBig Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no matter how risky it may be for the company.4 hr ago4 hr agoAustralia Pledges $735 Million to Kickstart Biofuels Industry5 hr ago5 hr agoGSK Pledges $30 Billion of US Investment as Trump Arrives in UK6 hr ago6 hr agoLilly’s Obesity Pill Will Have Far-Reaching Effect, Doctors Say7 hr ago7 hr agoBolsonaro Will Stay in Hospital Overnight After Feeling Sick9 hr ago9 hr agoEPA Proposes Large Refineries Offset Waived Biofuel Quotas11 hr ago11 hr agoGOP Unveils Bill to Avert Shutdown, Daring Democrats to Halt11 hr ago11 hr agoFDA Letters Flag Oprah Video, Morgan Freeman Ad in Crackdown12 hr ago12 hr agoECB Must Remain Agile Due to Lingering Uncertainty, Escriva Says12 hr ago12 hr agoSoybean Oil Rises for Fifth Day With Biofuel Demand in Focus14 hr ago14 hr agoMangione First-Degree Murder Charge in NY Case Is Dismissed15 hr ago15 hr agoNovo Nordisk Overhauls Senior Job Titles in Latest Shake-Up15 hr ago15 hr agoGreece’s New Fund Eyes €1 Billion Investment in Tech, RenewablesSean Dong for Bloomberg BusinessweekHow Hims Became the King of Knockoff Weight-Loss DrugsBig Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no matter how risky it may be for the company.HomeBTV+Market DataOpinionAudioOriginalsMagazineEventsNewsMarketsEconomicsTechnologyPoliticsGreenCryptoAIWork & LifeWealthPursuitsBusinessweekCityLabSportsEqualityManagement & WorkMarket DataStocksCommoditiesRates & BondsCurrenciesFuturesSectorsEconomic CalendarExploreNewslettersExplainersPointed News QuizThe Big TakeGraphicsSubmit a TipAbout UsTerms of ServiceDo Not Sell or Share My Personal InformationTrademarksPrivacy PolicyCareersMade in NYCAdvertiseAd ChoicesHelp©2025 Bloomberg L.P. All Rights Reserved.